<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/40A7BFF7-E338-48CC-87CE-2EC5F45A6B56"><gtr:id>40A7BFF7-E338-48CC-87CE-2EC5F45A6B56</gtr:id><gtr:name>St Mary's Hospital, London</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/91427003-DFB6-48F9-848A-32A456E1C00F"><gtr:id>91427003-DFB6-48F9-848A-32A456E1C00F</gtr:id><gtr:name>Royal Free Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:department>Department of Cellular and Molecular Sci</gtr:department><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/40A7BFF7-E338-48CC-87CE-2EC5F45A6B56"><gtr:id>40A7BFF7-E338-48CC-87CE-2EC5F45A6B56</gtr:id><gtr:name>St Mary's Hospital, London</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/91427003-DFB6-48F9-848A-32A456E1C00F"><gtr:id>91427003-DFB6-48F9-848A-32A456E1C00F</gtr:id><gtr:name>Royal Free Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8F97BFAC-A569-48D1-AB4C-2CFC6D3EC9E1"><gtr:id>8F97BFAC-A569-48D1-AB4C-2CFC6D3EC9E1</gtr:id><gtr:firstName>Derek</gtr:firstName><gtr:surname>Macallan</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B26F84B8-BD99-458F-87FD-67E85D1959E8"><gtr:id>B26F84B8-BD99-458F-87FD-67E85D1959E8</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Beverley</gtr:surname><gtr:orcidId>0000-0003-0481-2180</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500628"><gtr:id>275A648B-365B-432C-8132-829C4CC576E6</gtr:id><gtr:title>CCR5 and CXCR4 tropism and CD4 kinetics in HIV-1 infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500628</gtr:grantReference><gtr:abstractText>HIV infection causes disease by progressively depleting the number of a particular type of immune cells, ?CD4 cells?. We do not fully understand how infection results in loss of CD4 cells over time. Although HIV infects and destroys CD4 cells directly, the body normally just makes more cells to replace the lost ones. 

We believe that what determines how HIV affects the body?s CD4 cells is the exact type of cell it infects. There are several sub-types of CD4 cells. Different strains of virus prefer to infect different sub-types of CD4 cell according to the receptors (like locking devices) on the cell surface. Two receptors, ?CCR5? and ?CXCR4?, appear particularly important. We hypothesise that the interaction between the viral CCR5/CXCR4 preference (?tropism?), the type of cell infected and the speed at which those cells are dividing determines the long-term effect of HIV on CD4 cell numbers. 

To investigate this concept, we will measure how fast different sub-types of CD4 cells are dividing and disappearing within the body. Although much has been learnt from investigating cells and viruses in test tubes, answering such questions about CD4 loss can only be done by studying virus and CD4 cells within the body of people infected with HIV. We have recently developed a way of doing this using glucose containing an excess of deuterium. Deuterium is a naturally-occurring non-radioactive form (or isotope) of hydrogen which behaves exactly like hydrogen but can be measured using a mass spectrometer. We will give deuterium-labelled glucose (which is harmless) as a drink (half-hourly for 10 hours) to people with HIV infection, then take blood samples over the following 3 weeks. The glucose is used by dividing, but not non-dividing, cells to make new DNA. By separating the cells into their subtypes and measuring the deuterium in their DNA using a mass spectrometer, we can measure how fast CD4 subtypes divide and how long they survive in the body. We will also test the virus in the bloodstream for its CCR5/CXCR4 tropism. We will compare the results to those from a group of people without HIV infection. 

We will use these measurements to create a mathematical picture or ?model? of how HIV interacts with different immune cells to explain why CD4 cells are destroyed slowly over time and why changes in viral tropism trigger accelerated loss of CD4 cells.</gtr:abstractText><gtr:technicalSummary>Progressive loss of CD4+ T cells is the cardinal feature of HIV infection. However, the pivotal mechanisms which drive CD4 cell loss remain poorly understood. Although immune activation and accelerated CD4 cell turnover are thought to be important contributors to such loss, the chemokine tropism of the dominant viral strain appears to be critical. HIV-1 entry into CD4+ T cells depends on interaction between envelope, CD4 and a co-receptor, CCR5 or CXCR4 for R5 and X4 viruses respectively. R5 viruses dominate early in disease but a switch to X4 triggers more rapid CD4 decline. We hypothesise that the dominant viral tropism and the rate of CD4 decline is determined by the kinetics of the T cell subpopulations for which the virus is tropic. 

We propose to measure in vivo lymphocyte proliferation and death rates using deuterium-labelled glucose as a tracer for cell division in human volunteers. Specifically we aim to investigate: (1)The relative turnover rates of CCR5 and CXCR4 na?ve and memory lymphocytes in HIV-uninfected individuals, and (2) The effects of X4 and R5 viral strains on the turnover rates of CCR5 and CXCR4 na?ve and memory T cells in HIV-infected individuals before and after antiretroviral therapy. 
From the above we propose to define a quantitative kinetic model to explain why the switch from R5 to X4 tropic viruses is associated with accelerated CD4 T cell decline.

Subjects will receive 6,6-D2-glucose as an oral solution half-hourly for 10 hours, a methodology we have previously validated. Cells will be sorted according to expression of CD4, CD45, CCR5 and CXCR4 by flow cytometry, DNA will be extracted and analysed by gas chromatography mass spectrometry for deuterium content. Data will be modelled to yield proliferation and disappearance rates of individual cell populations. Data will be related to the dominant viral tropism.

We believe that the findings will have important implications for understanding the pathophysiology of HIV infection and explaining how CD4 depletion occurs. Such data would form the basis for developing novel immunological strategies for HIV infection and understanding the potential cellular impact of novel agents currently being developed to interfere with virus-chemokine interactions.</gtr:technicalSummary><gtr:fund><gtr:end>2008-04-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>264336</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Jenner Institute</gtr:department><gtr:description>Collaboration on Lymphocyte kinetics in HIV</gtr:description><gtr:id>A8052336-BD6E-4B9F-A161-115D3680838F</gtr:id><gtr:impact>Abstract presentation at CROI 2011</gtr:impact><gtr:outcomeId>178CC4A7026-1</gtr:outcomeId><gtr:partnerContribution>Collaboration in data analysis and interpretationCollaboration in data analysis, interpretation and presentationcollaboration on analysis of HIV viral tropismsCollaboration on mathematical modelling of lymphocyte kinetics</gtr:partnerContribution><gtr:piContribution>Clinical studies of turnover of CD4 T cells in HIV</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Free Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration on Lymphocyte kinetics in HIV</gtr:description><gtr:id>AEFE1148-AD66-4F05-ADB9-589BA0E014F8</gtr:id><gtr:impact>Abstract presentation at CROI 2011</gtr:impact><gtr:outcomeId>178CC4A7026-3</gtr:outcomeId><gtr:partnerContribution>Collaboration in data analysis and interpretationCollaboration in data analysis, interpretation and presentationcollaboration on analysis of HIV viral tropismsCollaboration on mathematical modelling of lymphocyte kinetics</gtr:partnerContribution><gtr:piContribution>Clinical studies of turnover of CD4 T cells in HIV</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Jenner Institute</gtr:department><gtr:description>Collaboration on Lymphocyte kinetics in HIV</gtr:description><gtr:id>AF3F34FF-5EB4-400F-8FC4-EAD34AE54501</gtr:id><gtr:impact>Abstract presentation at CROI 2011</gtr:impact><gtr:outcomeId>178CC4A7026-2</gtr:outcomeId><gtr:partnerContribution>Collaboration in data analysis and interpretationCollaboration in data analysis, interpretation and presentationcollaboration on analysis of HIV viral tropismsCollaboration on mathematical modelling of lymphocyte kinetics</gtr:partnerContribution><gtr:piContribution>Clinical studies of turnover of CD4 T cells in HIV</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Vaccine Research Center (VRC)</gtr:department><gtr:description>NIH</gtr:description><gtr:id>1F5A909E-DC77-436F-B956-B76DA55077B5</gtr:id><gtr:impact>New proposal currently being drafted</gtr:impact><gtr:outcomeId>6D588395C2D-1</gtr:outcomeId><gtr:partnerContribution>Development of new concepts and new projects. Learning new techniques and skills.</gtr:partnerContribution><gtr:piContribution>New collaboration with Dr R Koup's group at the Vaccine Research Center, at NIH Bethesda was developed in 2009. this builds on work dones as part of this MRC project.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St Mary's Hospital, London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration on Lymphocyte kinetics in HIV</gtr:description><gtr:id>EBDD00EF-24D6-475D-AC83-AFA4BD363341</gtr:id><gtr:impact>Abstract presentation at CROI 2011</gtr:impact><gtr:outcomeId>178CC4A7026-4</gtr:outcomeId><gtr:partnerContribution>Collaboration in data analysis and interpretationCollaboration in data analysis, interpretation and presentationcollaboration on analysis of HIV viral tropismsCollaboration on mathematical modelling of lymphocyte kinetics</gtr:partnerContribution><gtr:piContribution>Clinical studies of turnover of CD4 T cells in HIV</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Research Section of Molecular Haematology</gtr:department><gtr:description>Collaboration with KCH London on CLL</gtr:description><gtr:id>29FE1D39-CB27-4DD5-999D-7E46E8B0FCA7</gtr:id><gtr:impact>Award of two grants from Leukaemia Lymphoma Research</gtr:impact><gtr:outcomeId>oeRdrAve1J9-1</gtr:outcomeId><gtr:partnerContribution>Development of a new project to evaluate the effect of T cell inhibition on in vivo CLL Leukaemic cell turnover</gtr:partnerContribution><gtr:piContribution>Development of a new project to evaluate the effect of T cell inhibition on in vivo CLL Leukaemic cell turnover</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Lunch Club talk for elderly</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E25FE4A3-97C2-4D6A-8FD0-7C5185B9C18E</gtr:id><gtr:impact>about 50 mostly elderly people attended a talk on ageing and the immune system
&amp;quot;Lunch Plus&amp;quot; hosted by New Malden Baptist church, Surrey - 21/5/2012

Approached by several elderly people willing to participate in research</gtr:impact><gtr:outcomeId>PAtTBnSTzWP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50180</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LLR Project Grant</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:fundingRef>12064</gtr:fundingRef><gtr:id>ECB96A02-71A0-4D2A-AA2F-FE774079F2EC</gtr:id><gtr:outcomeId>eiJnggmFRd4</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>66918</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LLR project grant</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:fundingRef>12024</gtr:fundingRef><gtr:id>07112D57-B4E3-4955-88FA-163B190D9F06</gtr:id><gtr:outcomeId>ZieWzMVwHbC</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>With Dr Becca Asquith at Imperial College, we have developed approaches to analysis of lymphocyte labelling kinetics.
A publication manuscript has been submitted and is under review.</gtr:description><gtr:id>ADB524E1-EF18-4C6A-A140-803FD728EAEB</gtr:id><gtr:impact>Better understanding of labelling kinetics</gtr:impact><gtr:outcomeId>5460f4020ff7d7.14969158</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Models of Lymphocyte kinetics</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>As a result of this research we have developed novel models for understanding how CD4+ T cells interact with HIV to cause CD4 cell depletion.</gtr:description><gtr:id>BC0C7424-9C96-4153-AF8F-BD89CFFCCF4C</gtr:id><gtr:impact>To be published and disseminated</gtr:impact><gtr:outcomeId>751B20F3644</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Model of LC kinetics in HIV</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>As a result of this research we have developed new approaches to analysis of lymphocyte kinetics according to chemokine receptor expression. New cell sorting protocls were developed and new approaches to modelling of quantitative data were employed.</gtr:description><gtr:id>7CF46265-D213-4128-BAC2-61593AAF28EF</gtr:id><gtr:impact>Still to be published and disseminated</gtr:impact><gtr:outcomeId>3FC1256CCA0</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Analysis of LC kinetics by chemokine analysis</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>29E1EC66-EE10-4843-9E10-811436674B52</gtr:id><gtr:title>Lymphocyte kinetics in health and disease.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0647553140d22ce5daa9e5ac13040ca8"><gtr:id>0647553140d22ce5daa9e5ac13040ca8</gtr:id><gtr:otherNames>Asquith B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>sv7L1G1UhsA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0AFE2DC-C4F7-4B34-9714-1DB00B5CC00C</gtr:id><gtr:title>High production rates sustain in vivo levels of PD-1high simian immunodeficiency virus-specific CD8 T cells in the face of rapid clearance.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/833871a2c9f973bae8866fd14b00c736"><gtr:id>833871a2c9f973bae8866fd14b00c736</gtr:id><gtr:otherNames>Petrovas C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_16300_20_23824823</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F83146C0-3A2D-46F6-89EC-1D1976D6779A</gtr:id><gtr:title>Immune responses to HIV and vaccination</gtr:title><gtr:parentPublicationTitle>Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0aca4deeaa8267a51840c4d70aa933b2"><gtr:id>0aca4deeaa8267a51840c4d70aa933b2</gtr:id><gtr:otherNames>Macallan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>qEtxNRDyQp1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4072D2E7-485D-4655-B378-553AE5FB6D6C</gtr:id><gtr:title>Accelerated CD4(+) T cell turnover in HIV infection preferentially drives proliferation of CCR5(+) cells regardless of HIV viral co-receptor tropism</gtr:title><gtr:parentPublicationTitle>IMMUNOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88854b90c0811849cc38d9aa7a271807"><gtr:id>88854b90c0811849cc38d9aa7a271807</gtr:id><gtr:otherNames>Zhang Y.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>kzVwhghJ2Yq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2895092F-291F-4D82-8BB3-F707AF956222</gtr:id><gtr:title>Human lymphocyte dynamics and chronic viral infections</gtr:title><gtr:parentPublicationTitle>IMMUNOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65afcdc3afbf9fa922e8760d9b9a85d6"><gtr:id>65afcdc3afbf9fa922e8760d9b9a85d6</gtr:id><gtr:otherNames>Hegedus A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>RPxZwHDkLtx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D1F778F-2A67-403E-8AF3-549936814B07</gtr:id><gtr:title>Measurement of proliferation and disappearance of regulatory T cells in human studies using deuterium-labeled glucose.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05d303595cecc95b47227c65d510287e"><gtr:id>05d303595cecc95b47227c65d510287e</gtr:id><gtr:otherNames>Vukmanovic-Stejic M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>FmeDDRsQc8h</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9B30968-55C2-4D57-BA39-B02457E15786</gtr:id><gtr:title>Report from the second cytomegalovirus and immunosenescence workshop.</gtr:title><gtr:parentPublicationTitle>Immunity &amp; ageing : I &amp; A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bee66e5d800437620ae80666b3b0c95"><gtr:id>7bee66e5d800437620ae80666b3b0c95</gtr:id><gtr:otherNames>Wills M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-4933</gtr:issn><gtr:outcomeId>J62YXQGre7Q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>341F4719-DA49-4FBB-937E-E64C2EF68CE1</gtr:id><gtr:title>Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2beb0e5d39626113f74b8a15a597e4d6"><gtr:id>2beb0e5d39626113f74b8a15a597e4d6</gtr:id><gtr:otherNames>Wallace DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>ArGUfyds2QB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDB47632-F08D-4C61-9450-6A8BECAEA1E6</gtr:id><gtr:title>Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>YkizwLH7bdE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73CE7AAA-8E1C-481E-8D59-07D0F3084EAC</gtr:id><gtr:title>CD4+ T cell turnover is related to chemokine-receptor expression and HIV viral co-receptor tropism (Abstract)</gtr:title><gtr:parentPublicationTitle>Proceedings of the 17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f26cb5bfa9f32d91a39eef775c4fbec"><gtr:id>8f26cb5bfa9f32d91a39eef775c4fbec</gtr:id><gtr:otherNames>Macallan Derek</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>EF776B08B54</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64250ABD-03BA-45DE-B58D-93F5A95754B1</gtr:id><gtr:title>Quantitating lymphocyte homeostasis in vivo in humans using stable isotope tracers.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa75fc47d835a2ecb0db296abd211e72"><gtr:id>aa75fc47d835a2ecb0db296abd211e72</gtr:id><gtr:otherNames>Westera L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>5460f25b6f9a53.76268164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A689C3DC-09DA-4DD3-A34F-A1B96CA0911D</gtr:id><gtr:title>Immunosenescence and Cytomegalovirus: where do we stand after a decade?</gtr:title><gtr:parentPublicationTitle>Immunity &amp; ageing : I &amp; A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3d7b94b96c564cc8d50398b265aff7d"><gtr:id>e3d7b94b96c564cc8d50398b265aff7d</gtr:id><gtr:otherNames>Pawelec G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4933</gtr:issn><gtr:outcomeId>Dr8NX7VQ2xK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66026DBF-7BB3-4356-A7D7-252BD971DA6E</gtr:id><gtr:title>Measurement of proliferation and disappearance of rapid turnover cell populations in human studies using deuterium-labeled glucose.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cabc70d293c7a4e38f9015aecdd01633"><gtr:id>cabc70d293c7a4e38f9015aecdd01633</gtr:id><gtr:otherNames>Macallan DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>ZJRfwtyr98N</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>394199BE-3D2F-4509-8731-785DAB980B59</gtr:id><gtr:title>Protection versus pathology in aviremic and high viral load HIV-2 infection-the pivotal role of immune activation and T-cell kinetics.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26eb95f4f944a87818ca7d604e361952"><gtr:id>26eb95f4f944a87818ca7d604e361952</gtr:id><gtr:otherNames>Hegedus A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5460ef610199b3.61327503</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500628</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>